David E. Johnson

5.4k citations

117 papers · 3.9k indexed · h-index 37

Impact in

Endocrinology top 0.1%
- Escherichia coli research studies
- Vibrio bacteria research studies
- Enterobacteriaceae and Cronobacter Research
Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria

Papers in ⓘ

Endocrinology 28
- Escherichia coli research studies 25
- Vibrio bacteria research studies 10
Epidemiology 22
- Urinary Tract Infections Management 17

Co-authors: Harry L. T. Mobley (26 shared papers)C. Virginia Lockatell (23 shared papers)Xin Li (8 shared papers)Virginia Lockatell (5 shared papers)Michael S. Donnenberg (7 shared papers)Jennifer Snyder (4 shared papers)Hans Rollema (6 shared papers)Hui Zhao (5 shared papers)
Journals: Infection and Immunity (23 papers)European Journal of Pharmacology (3 papers)Molecular Microbiology (3 papers)Journal of the American Geriatrics Society (2 papers)The Journal of Urology (2 papers)
Partner nations: United States Thailand United Kingdom

In The Last Decade

David E. Johnson

110 papers receiving 3.7k citations

Peers

Countries citing papers authored by David E. Johnson

Since Specialization

Citations

This map shows the geographic impact of David E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Johnson more than expected).

Fields of papers citing papers by David E. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Johnson. The network helps show where David E. Johnson may publish in the future.

Co-authors

The 25 scholars most cited alongside David E. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Johnson Line = papers co-authored together David E. Johnson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Transcriptome of Uropathogenic Escherichia coli during Urinary Tract Infection Infection and Immunity ·Jennifer Snyder, Brian J. Haugen, Eric L. Buckles, C. Virginia Lockatell, David E. Johnson, Michael S. Donnenberg, Rodney A. Welch, Harry L. T. Mobley	2004	303
2	Role of Enterococcus faecalis Surface Protein Esp in the Pathogenesis of Ascending Urinary Tract Infection Infection and Immunity ·Nathan Shankar, C. Virginia Lockatell, Arto S. Baghdayan, Cinthia Drachenberg, Michael S. Gilmore, David E. Johnson	2001	272
3	Acute Effects of Atypical Antipsychotics on Whole-Body Insulin Resistance in Rats: Implications for Adverse Metabolic Effects Neuropsychopharmacology ·Karen L. Houseknecht, Alan S. Robertson, William J. Zavadoski, E. Michael Gibbs, David E. Johnson, Hans Rollema	2006	204
4	Role of Motility in the Colonization of Uropathogenic Escherichia coli in the Urinary Tract Infection and Immunity ·M. Chelsea Lane, Virginia Lockatell, Greta R. Monterosso, Daniel Lamphier, Julia Weinert, J. Richard Hebel, David E. Johnson, Harry L. T. Mobley	2005	190
5	Proteus mirabilis Genes That Contribute to Pathogenesis of Urinary Tract Infection: Identification of 25 Signature-Tagged Mutants Attenuated at Least 100-Fold Infection and Immunity ·Laurel S. Burall, Janette M. Harro, Xin Li, C. Virginia Lockatell, Stephanie D. Himpsl, J. Richard Hebel, David E. Johnson, Harry L. T. Mobley	2004	155
6	Isogenic P‐fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of α Gal(1–4)β Gal binding in virulence of a wild‐type strain Molecular Microbiology ·Harry L. T. Mobley, Karen G. Jarvis, John Elwood, Donna I. Whittle, C. Virginia Lockatell, Robert G. Russell, David E. Johnson, Michael S. Donnenberg, John W. Warren	1993	145
7	Border Theory: The Limits of Cultural Politics Project Muse (Johns Hopkins University) ·Scott Michaelsen, David E. Johnson	1997	120
8	Coordinate Expression of Fimbriae in Uropathogenic Escherichia coli Infection and Immunity ·Jennifer Snyder, Brian J. Haugen, C. Virginia Lockatell, Nathalie Maroncle, Erin C. Hagan, David E. Johnson, Rodney A. Welch, Harry L. T. Mobley	2005	111
9	Inhibitory Effects of Antipsychotics on Carbachol-Enhanced Insulin Secretion From Perifused Rat Islets Diabetes ·David E. Johnson, Hanae Yamazaki, Karen Ward, Anne W. Schmidt, Wesley Lebel, Judith L. Treadway, E. Michael Gibbs, Walter S. Zawalich, Hans Rollema	2005	108
10	In Vivo Phase Variation of Escherichia coli Type 1 Fimbrial Genes in Women with Urinary Tract Infection Infection and Immunity ·Jean K. Lim, Nereus W. Gunther, Hui Zhao, David E. Johnson, Susan Keay, Harry L. T. Mobley	1998	97
11	Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition Biochemical Pharmacology ·Hans Rollema, Mihály Hajós, Patricia A. Seymour, Rouba Kozak, Mark J. Majchrzak, Victor Guanowsky, W. Elliott Horner, Doug S. Chapin, William E. Hoffmann, David E. Johnson, Stafford McLean, Jody Freeman, Kathryn Williams	2009	95
12	Assessment of Virulence of Uropathogenic Escherichia coli Type 1 Fimbrial Mutants in Which the Invertible Element Is Phase-Locked On or Off Infection and Immunity ·Nereus W. Gunther, Jennifer Snyder, Virginia Lockatell, Ian C. Blomfield, David E. Johnson, Harry L. T. Mobley	2002	94
13	Autotransporter Genes pic and tsh Are Associated with Escherichia coli Strains That Cause Acute Pyelonephritis and Are Expressed during Urinary Tract Infection Infection and Immunity ·Susan R. Heimer, David A. Rasko, C. Virginia Lockatell, David E. Johnson, Harry L. T. Mobley	2003	87
14	In Vivo Dynamics of Type 1 Fimbria Regulation in Uropathogenic Escherichia coli during Experimental Urinary Tract Infection Infection and Immunity ·Nereus W. Gunther, Virginia Lockatell, David E. Johnson, Harry L. T. Mobley	2001	84
15	Visualization of Proteus mirabilis within the Matrix of Urease-Induced Bladder Stones during Experimental Urinary Tract Infection Infection and Immunity ·Xin Li, Hui Zhao, C. Virginia Lockatell, Cinthia B. Drachenberg, David E. Johnson, Harry L. T. Mobley	2002	76
16	In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract Molecular Microbiology ·Hui Zhao, Xin Li, David E. Johnson, Ian C. Blomfield, Harry L. T. Mobley	1997	67
17	Role of the K2 Capsule inEscherichia coliUrinary Tract Infection and Serum Resistance The Journal of Infectious Diseases ·Eric L. Buckles, Xiaolin Wang, M. Chelsea Lane, C. Virginia Lockatell, David E. Johnson, David A. Rasko, Harry L. T. Mobley, Michael S. Donnenberg	2009	64
18	Mannose-Resistant Proteus -Like Fimbriae Are Produced by Most Proteus mirabilis Strains Infecting the Urinary Tract, Dictate the In Vivo Localization of Bacteria, and Contribute to Biofilm Formation Infection and Immunity ·Angela Jansen, Virginia Lockatell, David E. Johnson, Harry L. T. Mobley	2004	62
19	Uropathogenicity in Rats and Mice of Providencia Stuartii from Long-Term Catheterized Patients The Journal of Urology ·David E. Johnson, C. Virginia Lockatell, Mary Hall-Craigs, Harry L. T. Mobley, John W. Warren	1987	62
20	Development of an Intranasal Vaccine To Prevent Urinary Tract Infection byProteus mirabilis Infection and Immunity ·Xin Li, C. Virginia Lockatell, David E. Johnson, M. Chelsea Lane, John W. Warren, Harry L. T. Mobley	2003	59

About David E. Johnson

David E. Johnson is a scholar working on Endocrinology, Epidemiology, Molecular Biology, Molecular Medicine and General Psychology, having authored 117 papers that have together received 3.9k indexed citations. Recurring topics across this work include Escherichia coli research studies (25 papers), Urinary Tract Infections Management (17 papers), Antibiotic Resistance in Bacteria (13 papers), Vibrio bacteria research studies (10 papers), Academic and Historical Perspectives in Psychology (9 papers), Gut microbiota and health (6 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Evaluation of Teaching Practices (4 papers). The work is most often cited by research in Endocrinology (1.6k citations), Molecular Medicine (604 citations), Biological Psychiatry (84 citations), Epidemiology (1.1k citations) and Clinical Biochemistry (181 citations). David E. Johnson has collaborated with scholars based in United States, Thailand and United Kingdom. Frequent co-authors include Harry L. T. Mobley, C. Virginia Lockatell, Xin Li, Virginia Lockatell, Michael S. Donnenberg, Jennifer Snyder, Hans Rollema, Hui Zhao, Scott Michaelsen and J. Richard Hebel. Their work appears in journals such as Infection and Immunity, European Journal of Pharmacology, Molecular Microbiology, Journal of the American Geriatrics Society and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact